Artículos por temáticas
En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.
Tema
Enfermedad de Parkinson
2601 ARTíCULOS , VIENDO DEL 1 AL 15
Wolff-Parkinson-white syndrome mimics a conduction disease.
Marrakchi S, Kammoun I, Kachboura S.
Case Rep Med. 2014;2014:789537. doi: 10.1155/2014/789537.
0
0
0
Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease.
Gao L, She H, Li W, Zeng J, Zhu J, Jones DP, Mao Z, Gao G, Yang Q.
Antioxid Redox Signal. 2014 Jun 20;20(18):2936-48. doi: 10.1089/ars.2013.5399.
0
0
0
Parkinson's drug could treat diabetic retinopathy.
Rosania K.
Lab Anim (NY). 2014 Mar;43(3):76. doi: 10.1038/laban.492. No abstract available.
0
0
0
Parkinson's disease: a brief review.
Campbell AW.
Adv Mind Body Med. 2014 Spring;28(2):4-5. Review. No abstract available.
0
0
0
Parkinson disease: Can a new trial end controversy over when to use levodopa?
Rascol O.
Nat Rev Neurol. 2014 Sep;10(9):488-9. doi: 10.1038/nrneurol.2014.147.
0
0
0
Targeting impulsivity in Parkinson's disease using atomoxetine.
Kehagia AA, Housden CR, Regenthal R, Barker RA, Müller U, Rowe J, Sahakian BJ, Robbins TW.
Brain. 2014 Jul;137(Pt 7):1986-97. doi: 10.1093/brain/awu117.
0
0
0
Ryan BJ, Lourenço-Venda LL, Crabtree MJ, Hale AB, Channon KM, Wade-Martins R.
Free Radic Biol Med. 2014 Feb;67:58-68. doi: 10.1016/j.freeradbiomed.2013.10.008.
0
0
0
Bir A, Sen O, Anand S, Khemka VK, Banerjee P, Cappai R, Sahoo A, Chakrabarti S.
J Neurochem. 2014 Dec;131(6):868-77. doi: 10.1111/jnc.12966.
0
0
0
Ageing and Parkinson's disease: why is advancing age the biggest risk factor?
Reeve A, Simcox E, Turnbull D.
Ageing Res Rev. 2014 Mar;14:19-30. doi: 10.1016/j.arr.2014.01.004. Review.
0
0
0
Noh SW, Han YH, Mun CW, Chung EJ, Kim EG, Ji KH, Seo JH, Kim SJ.
J Neurol Sci. 2014 Dec 15;347(1-2):210-3. doi: 10.1016/j.jns.2014.09.049.
0
0
0
A mitochondrial location for haemoglobins--dynamic distribution in ageing and Parkinson's disease.
Shephard F, Greville-Heygate O, Marsh O, Anderson S, Chakrabarti L.
Mitochondrion. 2014 Jan;14(1):64-72. doi: 10.1016/j.mito.2013.12.001.
0
0
0
Determinants of use of a walking device in persons with Parkinson's disease.
Bryant MS, Rintala DH, Graham JE, Hou JG, Protas EJ.
Arch Phys Med Rehabil. 2014 Oct;95(10):1940-5. doi: 10.1016/j.apmr.2014.06.002.
0
0
0
Sáez-Francàs N, Hernández-Vara J, Corominas-Roso M, Alegre J, Jacas C, Casas M.
J Neurol Sci. 2014 Feb 15;337(1-2):167-72. doi: 10.1016/j.jns.2013.12.003.
0
0
0
Major depressive disorder in Parkinson's disease: a cross-sectional study from Sri Lanka.
Ketharanathan T, Hanwella R, Weerasundera R, de Silva VA.
BMC Psychiatry. 2014 Sep 30;14:278. doi: 10.1186/s12888-014-0278-8.
0
0
0
Autogenic training shows short-term benefits in patients with early Parkinson's disease.
Sander R.
Nurs Older People. 2014 Oct;26(9):13. doi: 10.7748/nop.26.9.13.s20.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
